Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01401842 · ClinicalTrials.gov registry record · NA
Reduction of Risk for Low Back Injury in Theater of Operations
A NA study, sponsored by University of South Florida.
- Completed
- Registry status
- NA
- Development phase
- 582
- Enrollment target
NCT01401842: Completed NA study, sponsored by University of South Florida.
NCT01401842 is a NA study that has completed, run by University of South Florida. The registered enrollment target is 582 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (59% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01401842, a NA study, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 582 participants
- Enrollment target
Study Summary
The investigators will conduct a controlled clinical trial with U.S. Army soldiers training to become combat medics. The purpose of this study is to determine if a 11-week, high intensity exercise program targeting the low back muscles using specialized equipment will result in a 25% increase in low back muscular strength and endurance compared with a lower intensity general core stability exercise.
Primary Outcome
Isometric lumbar extension muscular strength (torque - Nm) as assessed by a validated physical performance test on the lumbar dynamometer
Interventions
- OTHER Lumbar ext. high intensity progressive resistance exercise
- OTHER Low intensity core stabilization exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 582 participants |
| Start Date | 2012-06 |
| Est. Completion | 2015-03 |
| Phase | NA |
What the finished NCT01401842 record still lists
NCT01401842 is an interventional study that assigns participants to a tested intervention. The registered 582 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (59% lower).
The record links to 0 conditions, and to 2 interventions - of which Lumbar ext. high intensity progressive resistance exercise is the first listed.
NCT01401842 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01401842 about?
NCT01401842 is a clinical study titled "Reduction of Risk for Low Back Injury in Theater of Operations". The investigators will conduct a controlled clinical trial with U.S. Army soldiers training to become combat medics. The purpose of this study is to determine if a 11-week, high intensity exercise program targeting the low back muscles using specialized equipment will result in a 25% increase in low...
What is the current status of trial NCT01401842?
This trial is currently completed. It is a NA study. The enrollment target is 582 participants. The study started on 2012-06. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01401842?
The interventions under investigation include: Lumbar ext. high intensity progressive resistance exercise (OTHER), Low intensity core stabilization exercise (OTHER).
Who is sponsoring clinical trial NCT01401842?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01401842's enrollment target sits among peer trials
582 177th of 2000 higher than 1,824 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06350097 · 582 participants · Phase 3
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
- NCT06563895 · 582 participants · Phase 3
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- NCT06819007 · 582 participants · Phase 3
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- NCT03840083 · 584 participants · NA
Sleep-dependent Learning in Aging
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia